Why should I cite TRI?
Citing TRI’s support for your research helps ensure the future of clinical and translational research at UAMS. The NIH requires investigators to cite TRI if they used any TRI resources to support their research or received funding through TRI. Additionally, TRI-supported researchers who publish must adhere to the NIH Public Access Policy.
The NIH Public Access Policy applies to all publications which cite TRI. Authors are responsible for ensuring that this process is completed and that your TRI cited manuscripts are compliant. Information about submitting to PubMed Central is available from NBCI at this link. You can also contact Christi Madden or Mtonya Hunter for assistance and questions.
From the NIH Website: SEC. 218
“The Director of the National Institutes of Health shall require that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication: Provided, That the NIH shall implement the public access policy in a manner consistent with copyright law.
The NIH Public Access Policy ensures that the public has access to the published results of NIH-funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central. The Policy requires that these final peer-reviewed manuscripts be accessible to the public on PubMed Central to help advance science and improve human health.”
Helpful Links for NIH Public Access Policy
NIH Public Access Policy Overview
Resources for Public Access Policy
When should I cite TRI?
Publications, presentations, or other outcomes resulting from research supported in whole or part by a Translational Research Institute (TRI) resource or service, and any faculty partially or fully supported by TRI are required to:
- Acknowledge the TRI by citing the appropriate grant(s).
- Ensure publications are submitted to PubMed Central and assigned a PMCID. (Instructions and assistance for authors can be found here).
Note: for research posters, presentations etc. resulting from your funded research, please also use the below language to acknowledge grant support.
Example language: “Research presented here was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number <insert appropriate grant number(s) here>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
Citation Language
“Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number <insert appropriate grant number(s) here>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
What constitutes TRI support?
Examples of TRI support include, but are not limited to, the following:
Investigators with pilot, voucher, or mini-grant funding, should cite TRI when the work was done while funded by TRI, or when downstream products directly benefited from pilot funding. Examples of these program include, but are not limited to:
- The UL1 Pilot Award Program,
- Clinical and Translational Science Pilot Program Awards (CTSP2),
- Strategies for Training and Advancing underrepresented Researchers Program (STARs)
- Inter-Institutional Pilot Awardees through the Consortium of Rural States (CORES)
- Community Based Participatory Research Scholars Awardees (CBPR)
- Winthrop P. Rockefeller Cancer Institute Rural Research Award Program
Investigators with K or T funding should cite TRI when the work was done while funded by TRI, or when downstream products directly benefitted from K or T research activities. Examples of these programs include:
- Funding through the Mentored Research Career Development Award (KL2 or K12)
- Funding through the Health Sciences Innovation and Entrepreneurship (HSIE) Training Program for Postdoctoral Fellows (TL1 or T32)
Implementation Science Scholars, and MS-CTS Scholars
Services and resources provided through the CTIU such as:
- Biostatistics, qualitative method or study design services received through the BERD
- Informatics resources received through CIRC
- Consulting services
- Research Collaboration support
- Proposal development services
- Navigator Support, or assistance from TRI personnel or CTIU services
Salary support (partial or full) that provides direct benefit to a publication or research product
Note: Downstream publications and research products resulting from non-TRI funded grants but for which the awarded proposal directly benefited from a resource or service should cite TRI.
Which award numbers should I use?
When citing TRI related awards, you should cite all award numbers under which you have received TRI’s support. Support is determined by the date of award.
- Multi-year awards should cite award numbers that correspond with both the initial notice of award date and any subsequent funding years. For example, an awardee who received year one of funding in 2023 and year two in 2024 would need to cite both UL1 TR003107 and UM1 TR004909If you have any questions about what constitutes support, when your support started, or which grants you should cite, please contact Christi Madden at CMadden2@uams.edu
- For training grants, if you participated in consultations or used TRI support in the development of your application, please cite the main funding award (a “U” number) and the appropriate training award number in your acknowledgement.
Use the tables below to identify which award number(s) you should cite.
Support received between 2024-2029:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2024 | 6/30/2029 | K12 TR004924 |
| NCATS | 7/1/2024 | 6/30/2029 | T32 TR004918 |
Support received between 2024-2031:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2024 | 6/30/2031 | UM1 TR004909 |
Support received between 2019-2024:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 7/1/2019 | 6/30/2024 | UL1 TR003107 |
| NCATS | 7/1/2019 | 6/30/2024 | KL2 TR003108 |
| NCATS | 7/1/2019 | 6/30/2024 | TL1 TR003109 |
Support received between 2009-2019:
| Sponsor | Start Date | End Date | Award ID |
| NCATS | 9/26/2017 | 6/30/2019 | U54 TR001629 |
| NCATS | 4/1/2012 | 3/31/2016 | KL2 TR000063 |
| NCATS | 4/1/2012 | 3/31/2016 | UL1 TR000039 |
| NCRR | 7/14/2009 | 3/31/2012 | UL1 RR029884 |
| NCRR | 7/14/2009 | 3/31/2012 | KL2 RR029883 |